More than a few decades, said Dr. Mark Hyman for the American Psychology Association, since researchers have hoped for a great leap in medical science in respect to the treatment of patients struggling with Generalized Anxiety Disorder, and now those hopes seem to have new basis in a clinical study proving for the first time that antidepressants are effective to treat chronic anxiety symptoms.
Often a chronic mental disorder, GAD is marked by too much anxiety, stress, and worry that influences daily life. Although both psychotherapy and a change in lifestyle are components of management, this new study reveals that among the most important instruments in the treatment of disorders are antidepressive medicines.
According to the meta-analysis of many clinical studies, SSRIs and SNRIs proved more successful in controlling anxiety-related symptoms. Such individuals who followed the prescribed drugs reported improved general mental health, less ongoing anxiety, and better mood.
They believe that their mechanism of action is really about achieving some kind of equilibrium in molecules like serotonin and norepinephrine that significantly affect mood management. According to the study, consistent use under medical monitoring greatly enhances the quality of life for GAD sufferers even though the entire impact cannot be seen right after few weeks.
Although many patients have some moderate side effects such nausea, tiredness, and dizziness upon receiving the meds, researchers believed that most of the time these are temporary symptoms. Apart from drug therapy, CBT also provides extra support, thereby augmenting the whole dimension of the treatment of the anxiety illness for improved therapeutic results.
For mental health experts, these results are great news since they inspire people who suffer with chronic anxiety to consult a doctor and avoid fearing therapy. This study underlined that GAD is a treatable condition for which the correct drugs, therapies, and self-maintenance can help people lead active lives free from worry.
